78 related articles for article (PubMed ID: 19423319)
1. Mukitake mushroom (Panellus serotinus) alleviates nonalcoholic fatty liver disease through the suppression of monocyte chemoattractant protein 1 production in db/db mice.
Nagao K; Inoue N; Inafuku M; Shirouchi B; Morooka T; Nomura S; Nagamori N; Yanagita T
J Nutr Biochem; 2010 May; 21(5):418-23. PubMed ID: 19423319
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of fractional extracts from Panellus serotinus on non-alcoholic fatty liver disease in obese, diabetic db/db mice.
Inafuku M; Nagao K; Nomura S; Shirouchi B; Inoue N; Nagamori N; Nakayama H; Toda T; Yanagita T
Br J Nutr; 2012 Mar; 107(5):639-46. PubMed ID: 21787451
[TBL] [Abstract][Full Text] [Related]
3. Effect of Mukitake mushroom (Panellus serotinus) on the pathogenesis of lipid abnormalities in obese, diabetic ob/ob mice.
Inoue N; Inafuku M; Shirouchi B; Nagao K; Yanagita T
Lipids Health Dis; 2013 Feb; 12():18. PubMed ID: 23406154
[TBL] [Abstract][Full Text] [Related]
4. Effects of lotus root (the edible rhizome of Nelumbo nucifera) on the deveolopment of non-alcoholic fatty liver disease in obese diabetic db/db mice.
Tsuruta Y; Nagao K; Shirouchi B; Nomura S; Tsuge K; Koganemaru K; Yanagita T
Biosci Biotechnol Biochem; 2012; 76(3):462-6. PubMed ID: 22451385
[TBL] [Abstract][Full Text] [Related]
5. Eicosapentaenoic acid-containing polar lipids from seaweed Susabinori (Pyropia yezoensis) alleviate hepatic steatosis in obese db/db mice.
Yanagita T; Tsuge K; Koga M; Inoue N; Nagao K
Arch Biochem Biophys; 2020 Sep; 691():108486. PubMed ID: 32710880
[TBL] [Abstract][Full Text] [Related]
6. Dietary phosphatidylinositol prevents the development of nonalcoholic fatty liver disease in Zucker (fa/fa) rats.
Shirouchi B; Nagao K; Inoue N; Furuya K; Koga S; Matsumoto H; Yanagita T
J Agric Food Chem; 2008 Apr; 56(7):2375-9. PubMed ID: 18324772
[TBL] [Abstract][Full Text] [Related]
7. Chromium attenuates high-fat diet-induced nonalcoholic fatty liver disease in KK/HlJ mice.
Chen WY; Chen CJ; Liu CH; Mao FC
Biochem Biophys Res Commun; 2010 Jul; 397(3):459-64. PubMed ID: 20513351
[TBL] [Abstract][Full Text] [Related]
8. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis.
Beraza N; Malato Y; Vander Borght S; Liedtke C; Wasmuth HE; Dreano M; de Vos R; Roskams T; Trautwein C
Gut; 2008 May; 57(5):655-63. PubMed ID: 18408102
[TBL] [Abstract][Full Text] [Related]
10. Diabetes of the liver: the link between nonalcoholic fatty liver disease and HFCS-55.
Collison KS; Saleh SM; Bakheet RH; Al-Rabiah RK; Inglis AL; Makhoul NJ; Maqbool ZM; Zaidi MZ; Al-Johi MA; Al-Mohanna FA
Obesity (Silver Spring); 2009 Nov; 17(11):2003-13. PubMed ID: 19282820
[TBL] [Abstract][Full Text] [Related]
11. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice.
Wang Q; Jiang L; Wang J; Li S; Yu Y; You J; Zeng R; Gao X; Rui L; Li W; Liu Y
Hepatology; 2009 Apr; 49(4):1166-75. PubMed ID: 19177596
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
[TBL] [Abstract][Full Text] [Related]
14. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
Hookman P; Barkin JS
Am J Gastroenterol; 2003 Sep; 98(9):2093-7. PubMed ID: 14499793
[TBL] [Abstract][Full Text] [Related]
15. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice.
Coenen KR; Hasty AH
Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E492-9. PubMed ID: 17566116
[TBL] [Abstract][Full Text] [Related]
16. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2.
Haukeland JW; Damås JK; Konopski Z; Løberg EM; Haaland T; Goverud I; Torjesen PA; Birkeland K; Bjøro K; Aukrust P
J Hepatol; 2006 Jun; 44(6):1167-74. PubMed ID: 16618517
[TBL] [Abstract][Full Text] [Related]
17. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
18. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease.
Targher G; Bertolini L; Rodella S; Zoppini G; Scala L; Zenari L; Falezza G
Clin Endocrinol (Oxf); 2006 Jun; 64(6):679-83. PubMed ID: 16712671
[TBL] [Abstract][Full Text] [Related]
19. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
20. Serum ornithine carbamyltransferase reflects hepatic damage in diabetic obese mice.
Murayama H; Ikemoto M; Hamaoki M
J Gastroenterol Hepatol; 2010 Feb; 25(2):413-9. PubMed ID: 19793175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
